178 related articles for article (PubMed ID: 1956033)
1. Synthesis, molecular modeling studies, and muscarinic receptor activity of azaprophen analogues.
Triggle DJ; Kwon YW; Abraham P; Pitner JB; Mascarella SW; Carroll FI
J Med Chem; 1991 Nov; 34(11):3164-71. PubMed ID: 1956033
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and muscarinic receptor activity of ester derivatives of 2-substituted 2-azabicyclo[2.2.1]heptan-5-ol and -6-ol.
Carroll FI; Abraham P; Chemburkar S; He XC; Mascarella SW; Kwon YW; Triggle DJ
J Med Chem; 1992 Jun; 35(12):2184-91. PubMed ID: 1613746
[TBL] [Abstract][Full Text] [Related]
3. 6-Methyl-6-azabicyclo[3.2.1]octan-3 alpha-ol 2,2-diphenylpropionate (azaprophen), a highly potent antimuscarinic agent.
Carroll FI; Abraham P; Parham K; Griffith RC; Ahmad A; Richard MM; Padilla FN; Witkin JM; Chiang PK
J Med Chem; 1987 May; 30(5):805-9. PubMed ID: 3494849
[TBL] [Abstract][Full Text] [Related]
4. Crystal, solution, and molecular modeling structural properties and muscarinic antagonist activity of azaprophen.
Carroll FI; Abraham P; Mascarella SW; Singh P; Moreland CG; Sankar SS; Kwon YW; Triggle DJ
J Med Chem; 1991 Apr; 34(4):1436-40. PubMed ID: 2016720
[TBL] [Abstract][Full Text] [Related]
5. Stereoselective recognition of the enantiomers of phenglutarimide and of six related compounds by four muscarinic receptor subtypes.
Waelbroeck M; Lazareno S; Pfaff O; Friebe T; Tastenoy M; Mutschler E; Lambrecht G
Br J Pharmacol; 1996 Dec; 119(7):1319-30. PubMed ID: 8968538
[TBL] [Abstract][Full Text] [Related]
6. 6beta-Acyloxy(nor)tropanes: affinities for antagonist/agonist binding sites on transfected and native muscarinic receptors.
Daly JW; Gupta TH; Padgett WL; Pei XF
J Med Chem; 2000 Jun; 43(13):2514-22. PubMed ID: 10891110
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of 2-(3-substituted-1,2,4-oxadiazol-5-yl)-8-methyl-8-azabicyclo [3.2.1]octanes and 2 alpha-(3-substituted-1,2,4-oxadiazol-5-yl)-8-methyl-8- azabicyclo[3.2.1]oct-2-enes as potential muscarinic agonists.
Triggle DJ; Kwon YW; Abraham P; Rahman MA; Carroll FI
Pharm Res; 1992 Nov; 9(11):1474-9. PubMed ID: 1475236
[TBL] [Abstract][Full Text] [Related]
8. M3/M1-Selective antimuscarinic tropinyl and piperidinyl esters.
Xu R; Sim MK; Go ML
Eur J Pharm Sci; 1999 Apr; 8(1):39-47. PubMed ID: 10072477
[TBL] [Abstract][Full Text] [Related]
9. Further evidence for the heterogeneity of functional muscarinic receptors in guinea pig gallbladder.
Akici A; Karaalp A; Iskender E; Christopoulos A; El-Fakahany EE; Oktay S
Eur J Pharmacol; 2000 Jan; 388(1):115-23. PubMed ID: 10657554
[TBL] [Abstract][Full Text] [Related]
10. Muscarinic receptor subtype specificity of (N,N-dialkylamino)alkyl 2-cyclohexyl-2-phenylpropionates: cylexphenes (cyclohexyl-substituted aprophen analogues).
Leader H; Gordon RK; Baumgold J; Boyd VL; Newman AH; Smejkal RM; Chiang PK
J Med Chem; 1992 Apr; 35(7):1290-5. PubMed ID: 1560441
[TBL] [Abstract][Full Text] [Related]
11. L-689,660, a novel cholinomimetic with functional selectivity for M1 and M3 muscarinic receptors.
Hargreaves RJ; McKnight AT; Scholey K; Newberry NR; Street LJ; Hutson PH; Semark JE; Harley EA; Patel S; Freedman SB
Br J Pharmacol; 1992 Oct; 107(2):494-501. PubMed ID: 1422595
[TBL] [Abstract][Full Text] [Related]
12. Discriminative stimulus properties of the muscarinic receptor agonists Lu 26-046 and O-Me-THPO in rats: evidence for involvement of different muscarinic receptor subtypes.
Arnt J; Lembøl HL; Meier E; Pedersen H
Eur J Pharmacol; 1992 Jul; 218(1):159-69. PubMed ID: 1397027
[TBL] [Abstract][Full Text] [Related]
13. The design and pharmacology of novel selective muscarinic agonists and antagonists.
Lambrecht G; Gross J; Hacksell U; Hermanni U; Hildebrandt C; Hou X; Moser U; Nilsson BM; Pfaff O; Waelbroeck M
Life Sci; 1995; 56(11-12):815-22. PubMed ID: 10188780
[TBL] [Abstract][Full Text] [Related]
14. The interaction of the enantiomers of aceclidine with subtypes of the muscarinic receptor.
Ehlert FJ; Griffin MT; Glidden PF
J Pharmacol Exp Ther; 1996 Dec; 279(3):1335-44. PubMed ID: 8968358
[TBL] [Abstract][Full Text] [Related]
15. Binding and functional properties of antimuscarinics of the hexocyclium/sila-hexocyclium and hexahydro-diphenidol/hexahydro-sila-diphenidol type to muscarinic receptor subtypes.
Waelbroeck M; Tastenoy M; Camus J; Christophe J; Strohmann C; Linoh H; Zilch H; Tacke R; Mutschler E; Lambrecht G
Br J Pharmacol; 1989 Sep; 98(1):197-205. PubMed ID: 2804545
[TBL] [Abstract][Full Text] [Related]
16. Subtype selectivity of the positive allosteric action of alcuronium at cloned M1-M5 muscarinic acetylcholine receptors.
Jakubík J; Bacáková L; el-Fakahany EE; Tucek S
J Pharmacol Exp Ther; 1995 Sep; 274(3):1077-83. PubMed ID: 7562472
[TBL] [Abstract][Full Text] [Related]
17. Structural comparison of the potent antimuscarinic agent azaprophen hydrochloride with aprophen hydrochloride and structurally related antimuscarinic agents.
Karle JM; Karle IL; Chiang PK
Acta Crystallogr B; 1990 Apr; 46 ( Pt 2)():215-22. PubMed ID: 2344395
[TBL] [Abstract][Full Text] [Related]
18. Affinity profiles of hexahydro-sila-difenidol analogues at muscarinic receptor subtypes.
Lambrecht G; Feifel R; Wagner-Röder M; Strohmann C; Zilch H; Tacke R; Waelbroeck M; Christophe J; Boddeke H; Mutschler E
Eur J Pharmacol; 1989 Sep; 168(1):71-80. PubMed ID: 2583233
[TBL] [Abstract][Full Text] [Related]
19. Affinity and selectivity of the optical isomers of 3-quinuclidinyl benzilate and related muscarinic antagonists.
Rzeszotarski WJ; McPherson DW; Ferkany JW; Kinnier WJ; Noronha-Blob L; Kirkien-Rzeszotarski A
J Med Chem; 1988 Jul; 31(7):1463-6. PubMed ID: 3385735
[TBL] [Abstract][Full Text] [Related]
20. SB 202026: a novel muscarinic partial agonist with functional selectivity for M1 receptors.
Loudon JM; Bromidge SM; Brown F; Clark MS; Hatcher JP; Hawkins J; Riley GJ; Noy G; Orlek BS
J Pharmacol Exp Ther; 1997 Dec; 283(3):1059-68. PubMed ID: 9399977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
